The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, according to the drug's maker, Gilead Sciences
The drug, sold under the brand name Veklury, has been used under emergency use authorization. It is the first drug to be approved for treating Covid-19."In the United States, Veklury is indicated for adults and pediatric patients for the treatment of COVID-19 requiring hospitalization," the company said in a statement.Get CNN Health's weekly newsletter Sign up here to get The Results Are In with Dr. Sanjay Gupta every Tuesday from the CNN Health team.
"Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care."Earlier this month, a World Health Organization-sponsored global study found remdesivir did not help patients survive or even recover faster, but a US study found the infused drug shortened recovery time for some patients by about a third.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. FDA panel to discuss COVID-19 vaccine trials after emergency authorizationA panel of independent experts to the U.S. health regulator will decide on the nature of clinical trials that coronavirus vaccines should go through after receiving U.S. emergency use authorization.
Weiterlesen »
FDA extends Covid-19 vaccine meeting to allow public inputThe FDA has added extra time to a daylong meeting Thursday of its vaccine advisers. The meeting will now include at least an hour and a half for public input, according to an agenda posted online.
Weiterlesen »
FDA Approves Remdesivir For Covid-19 TreatmentThe drug was previously granted emergency use authorization, not full approval.
Weiterlesen »
Gilead's remdesivir gets U.S. FDA approval for use in hospitalized COVID-19 patientsGilead said it is currently meeting real-time demand for remdesivir, which is sold under the brand name Veklury, in the United States and anticipates meeting global demand by the end of October. Remdesivir, previously granted emergency use authorization by the FDA for COVID-19, was one of the drugs
Weiterlesen »
Utah heart attack victim competes for medical care amid surge in Covid-19 casesUtah is experiencing 'one of the worst (coronavirus) outbreaks in the country,' Gov. Garry Herbert said Tuesday. As a result, patients suffering other life-threatening medical events are in a dangerous competition for limited specialized medical care.
Weiterlesen »